We should group all the PrEP, PEP, and early treatment studies of HCQ together at the point at which we see temporal and dose dependent effects time and again. Such research should certainly be separated out, but at the point at which signs of antiviral action emerge so consistently, that observation ties the body of evidence together.
Pulmonary and critical care specialist Dr. Pierre Kory, author of the medical textbook Point of Care Ultrasound, is an educator and self-described pioneer in teaching doctors how to use ultrasound machines. In response to global health organizations’ seemingly one-note strategy in the fight against Covid, Kory states that other tactics need to be applied, particularly in light of the numerous breakthrough infections.
The May 2021 issue of Antibiotics Review, for example, put out a metanalysis of ivermectin which showed that 100% of 36 prophylaxis and early treatment studies showed positive results, and 26 of the studies showed “statistically significant improvements.”
Five months after receiving the Pfizer vaccine, protection in Israel against mild-to-moderate disease was only 15 per cent. The unpredictable nature of new variants leads to an increasing realisation that a COVID-free community in Australia will not happen without draconian and continued lockdowns. There is an immediate need for early drug therapy to complement the vaccine program.
We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with the Delta variant. The Delta, which represents the vast majority of new cases in the US and many other countries, requires indeed a slightly different approach for its early treatment.
The latest information about:
the Delta variant;
asymptomatic transmission and testing;
natural immunity from having a covid-19 infection vs vaccination;
what to do if you have symptoms;
testing;
the use of nutraceuticals;
treatment protocols;
the use of hydroxychloroquine and ivermectin;
putting to rest the question of hydroxychloroquine and adverse cardiological effects;
gastrointestinal symptoms of Delta;
being aware of our state of health;
oral and dental hygiene;
the use of monoclonal antibodies including Regeneron, Remdesivir and full dose blood thinners;
outpatient followup;
long hauler Covid;
myocarditis;
the commencement of early treatment;
the role of fever in the disease process;
the use of NSAIDs;
obesity as a risk factor;
talking to your physician;
the failure of vaccines.
Two doses (300 μg/kg/dose in a gap of 72 hours) of ivermectin chemoprophylaxis reduced COVID-19 infection by 83% among HCWs for one month. Ivermectin is a safe and effective strategy to prevent COVID-19, in the containment of pandemic alongside vaccine. Further research is required to guide the frequency of chemoprevention, acceptability, and cost-effectiveness in the community setting.
Over the past four months, E-BMC Ltd has been working together with the FLCCC to encourage governments around the world to adopt re-purposed existing drugs for the early treatment of
covid-19. One such drug is Ivermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections. properties as well. E-BMC Ltd’s comprehensive meta-analysis, which has now been published in the peer-reviewed American Journal of Therapeutics, shows that “moderate-certainty evidence” points to a substantial reduction in Covid-19 related deaths with the use of ivermectin.
Borody’s ivermectin triple therapy prophylactic is the perfect solution. It reduces transmission immediately, regardless of the variant, by preventing the virus from entering a person’s cells. It also shortens time spent in quarantine and reduces transmission to close contacts. Early treatment dramatically reduces hospitalisation and mortality and would rapidly end the Sydney wave, as similar therapies did in Mexico and India. It would also put an end to any need for masks and lockdowns.
It’s all so cruel and unnecessary. With or without Professor Skerritt, if doctors prescribed ivermectin therapy for every person who tests positive, and wants it, and for their close contacts, the Delta wave would wash away. Offer it to the vaccine-hesitant and anyone seeking protection until they were vaccinated, and we could reopen our borders. How apposite that the escape route out of our pandemic prison could be as Aussie as Vegemite.
Dr. Vladimir Zelenko talks with author John Leake about treating his patients for Covid-19 and then sharing his insight with the White House. In spite of (or because of) President Trump’s initial embrace of Dr. Zelenko’s treatment protocol, government agencies such as the NIH and FDA first dismissed it, and then prevented public access to its key ingredient, hydroxychloroquine. This deliberate suppression of a life saving medication led to the preventable deaths of hundreds of thousands of Americans.
Source: Rounding The Earth Author: Mathew Crawford Since sometime last summer, I’ve paid (increasing) attention to much of the rapidly growing body of evidence that ivermectin (IVM)
During the first wave, the primary antiviral used was HCQ, and during the second wave (after Facebook censored his account where he was communicating with others in a large nation) they shifted to ivermectin due to HCQ controversies. Similarly to the way Dr. Brian Tyson attacked COVID-19 with an early multi-drug regimen, numerous other medicines, including aspirin, were used. Of Dr. Shah’s 8,000 or so patients, only 5 succumbed to COVID-19. This is notably similar to the results of Dr. Didier Raoult.
Source: India Today Author: Prabhash K Dutta Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year,
Bret, Pierre, Heather, and a large number of internet pundits make a great case that suppression of ivermectin is a large, gross, and inhumane crime. However, this is not the “crime of the century”. The crime of the century is far larger, or rather more systemic.
Both Goa and Karnataka are rolling out mass Ivermectin programs in a bid to reduce infection, transmission, and death rates associated with COVID-19. TrialSite reported two days ago that the State of Goa embraced the national Ivermectin guidelines, and as reported in The Mint and other outlets, Vishwajit Rane, Goa’s Health Minister, declared that all people 18 years and up would have access to the generic drug regardless of COVID-19 status in an aggressive bid to lower infection rates and total deaths associated with SARS-CoV-2.
We are very honored to present this interview of Dr Vladimir Zelenko, the father of outpatient treatment for COVID-19 in North America. Dr Zelenko shares his own experience with COVID-19 as a patient, as he is recovering from a severe form of the disease.
He also talks about his cancer and how he was able to go through this dramatic episode of his life. Then, he presents his perspectives about outpatient treatment as practiced today and the evolution of the pandemic, among other topics.
At this point, continuing the use of Ivermectin has proven safe and we see no reason to stop this drug, which seems to have not only inhibited our second wave but so far prevented a third one.
If you were going to try and design a drug, for the disease that we call COVID-19, you would want something with heavy anti-viral properties, as well as anti-inflammatory properties.
When you think about that, it’s hard to come up with a better drug for Covid than ivermectin. It literally does both of those things simultaneously, and it’s one of the safest drugs known to man.
The International Ivermectin for Covid Conference: Dr. David Chesler shares his experience of using ivermectin to prevent and treat covid-19 infection amongst care home residents.
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. In this talk, speaker Dr. Mobeen Syed provides an overview of ivermectin and how it works against covid-19.
While HCQ looks very safe overall for COVID-19 patients, it looks safest when used as a prophylactic or therapeutic for early stage COVID-19 patients, once again affirming the Primary HCQ Hypothesis as the strongest version of the HCQ Hypothesis.
The purpose of this study was to assess the effect of oral Ivermectin treatment, which has been associated with iota-carrageenan in repeated doses through the nasal and oral topical route, on the appearance and eventual progression of COVID-19 disease in a healthy population that are exposed to it and have a higher risk of contagion of SARS-COV-2 for being health personnel from
Source: Communities Digital News Author: Rick Johnson LOS ANGELES, CA: As the COVID-19 pandemic explodes in the New York region and across California, the Malaria
We conclude that two-dose ivermectin prophylaxis at a dose of 300 μg/kg body weight with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among HCWs in the following one month. Chemoprophylaxis has relevance in the containment of pandemic. This is an intervention worth replicating at other centers until a vaccine is widely available.
I know I do catch COVID-19, I know what to take. My doctor has provided hydroxychloroquine, which I’m taking every day.
Source: St Vincent’s Hospital Melbourne Healthcare workers are part of the first line of defence in today’s fight against COVID-19. But as this global virus
The American media and bureaucracies should move beyond their obsession with politics and honestly consider HCQ’s efficacy.
Our data suggest that chronic treatment with HCQ confer protection against SARS-CoV-2 infection.
Source: Vanguard Nigeria Preliminary trials on the use of chloroquine and hydroxychloroquine as prophylaxis for COVID-19 in Nigeria has recorded some level of success. The
“As far as prophylaxis is concerned, more than 4,300 doctors and health works were given HCQ as approved by Indian Council of Medical Research (ICMR) out of which around 45 health persons tested positive and recovered later,”
A Sungai Buloh Hospital clinician also described the controversial antimalarial drug, hydroxychloroquine, as an anchor during the peak of the Covid-19 crisis in Malaysia.
Source: MedRxiv Abstract Background: While several trials are ongoing for treatment of COVID-19, scientific research on chemoprophylaxis is still lacking even though it has potential
Source: Times of India Nagpur: Preventive measures taken by city police’s medical teams seemed to have worked better for them in comparison to their counterparts
Source: AAPS Today, June 2, 2020, the Association of American Physicians & Surgeons (AAPS) filed a lawsuit, AAPS v. FDA, against the Food and Drug Administration
Source: Hindustan Times The results of the study are based on a case control study for which participants were randomly drawn from the countrywide Covid-19
Source: Argus Leader South Dakota’s study of an antimalarial drug’s impact on the coronavirus can’t be compared to other studies halted, a Sanford Health leader said.
Source: Reuters SAN SALVADOR (Reuters) – Salvadoran President Nayib Bukele said on Tuesday he takes hydroxychloroquine, an antimalarial drug that U.S. President Trump has promoted
Source: India.com New Delhi: Two days after the World Health Organisation (WHO) put a pause on clinical trials of hydroxychloroquine (HCQ) for COVID-19, the Council of
Source: The Western Journal President Donald Trump is leading by example. On the advice of his physicians, he has been taking hydroxychloroquine on a prophylactic
